INS and diabetes mellitus: Rosenstock et al. managed two trials assessing the safety and efficacy of empagliflozin treatment in patients inadequately controlled on their current diabetes treatment (patients inadequately controlled on basal insulin [110] and on multiple daily injections of insulin [111]).